Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Iamgold Corporation Ordinary Shares (IAG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Iamgold Corporation Ordinary Shares — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Iamgold Corporation Ordinary Shares trades at $18.8 (market cap $10.49B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Iamgold Corporation Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Iamgold Corporation Ordinary Shares for 1 Days on average.
| HALO | IAG | |
|---|---|---|
Market Cap | $12.58B | $10.49B |
Volume | 2,179,278 | 3,160,902 |
Sector | Health | Basic Materials |
52-Week High | $115.22 | $24.57 |
52-Week Low | $61.63 | $10.96 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $10.53B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Iamgold Corporation Ordinary Shares
IAMGOLD is a gold mining company with operations in Canada. It also explores and develops gold properties.
Read more on IAG →
